McGraw-Hill Professional, part of education materials publisher McGraw-Hill Education, has published the latest edition of Pharmacotherapy: A Pathophysiologic Approach. Now in its seventh edition, the reference is projected to set the standard in therapeutics courses in North American schools of pharmacy and act as a trusted reference for those in practice.
The reference provides evidence-based approaches to the drug treatment of diseases. Like the discipline it covers, it is seen to go beyond drug indications and dosages to include the initial selection, proper administration and monitoring of drugs.
Featuring full-colour throughout for the first time, the revised version contains expanded evidence-based recommendations and extended coverage of the issue of palliative care and pain medicine. It now also includes web-based chapters, as well as new chapters including Drug Therapy Individualization: Patients with Hepatic Disease; Primary Pulmonary Hypertension, Management of the Developmentally Disabled, Substance Abuse, Drug Therapy of Influenza, and Psychosomatic Medicine.
Academic features include "Key Concepts" highlighted in each chapter; clinical presentation boxes summarising the most common disease signs and symptoms covered in each chapter; "Clinical Controversies" boxes presented in the Treatment sections of the disease-oriented chapters that examine the complicated issues faced by students and clinicians in providing drug therapy; clear therapeutic recommendations in each disease-specific chapter; and "Evaluation of Therapeutic Outcomes" boxes in each disease-specific chapter, containing key monitoring guidelines that facilitate the development of a pharmaceutical, nursing or medical care plan.
